High-fat diet from perilla oil induces insulin resistance despite lower serum lipids and increases hepatic fatty acid oxidation in rats
© Zhang et al.; licensee BioMed Central Ltd. 2014
Received: 23 October 2013
Accepted: 2 January 2014
Published: 15 January 2014
The purpose of this study is to investigate the effects of a high-fat diet from perilla oil on serum lipids, hepatic lipid metabolism and insulin sensitivity.
Male Sprague–Dawley (SD) rats were fed either a control (CT) diet or a diet high in perilla oil (HP). After 16 weeks of feeding, the serum lipids were measured, and the gene expressions involved in hepatic fatty acid oxidation and synthesis were determined. In addition, hepatic fat deposition was detected, and insulin sensitivity was evaluated by means of euglycemic-hyperinsulinemic clamp.
Compared with the rats in the CT group, the HP-feeding significantly decreased the levels of triglyceride (TG), total cholesterol (TCH) and HDL-cholesterol (HDL-c). HP-feeding did not change the levels of LDL-cholesterol (LDL-c), free fatty acid (FFA), intrahepatic lipids or body weight. Moreover, the HP-feeding dramatically increased the mRNA expressions of fatty acid oxidation markers (PPAR-alpha, CPT1A) and fatty acid synthesis markers (SREBP-1, FASN and ACC) in the liver. The HP-feeding induced increased protein levels of CPT1A, while reducing the protein levels of FASN and ACC in the liver. However, the glucose infusion rate significantly increased in the HP group compared with the CT group.
Our data show that, in rats, excessive perilla oil intake may significantly lower serum lipids, strengthen hepatic fatty acid oxidation, and inhibit hepatic fatty acid synthesis, but at the same time may also lead to insulin resistance.
KeywordsPerilla oil Alpha-linolenic acid Serum lipid Fatty acid oxidation Insulin sensitivity
Epidemiological evidence suggests that a western diet rich in fat is associated with obesity, NALFD and insulin resistance [1, 2]. In order to investigate the effects of high fat diet on bodies, a large number of experiments have employed high-fat diet-induced animal models [3–5]. A multitude of different high-fat diets have been used with relative fat fractions between 20 and 60% energy as fat, and the basic fat component varies between animal derived fats and plant oils . However, the characteristics of the animal models induced by high-fat diets from various fat sources are different. In our previous experiments, semi-purified diets with fat consisting of 45.73% energy based on animal fats and n-6 fatty acid-containing plant oils led to obesity and NALFD, whereas diets with the same amounts of linseed oil, which were rich in ALA (>55% of total FA), did not .
Perilla is one of the richest sources of ALA. ALA and other fatty acids may be transformed into long-chain polyunsaturated fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), via a series of elongation and desaturation reactions . Delta-6-desaturase catalyzes rate-limiting enzymatic reactions in humans. Two long-chain n-3 PUFAs (EPA and DHA) from fish oil have been widely recognized due to their beneficial effects on health, and are considered as essential supplements in human food . Many studies have shown that n-3 PUFAs play roles in resisting inflammation, increasing insulin sensitivity, and reducing the incidences of obesity and cardiovascular and cerebrovascular diseases [10–12]. In rodents in vivo, n-3 long-chain-PUFA has been shown to have a protective effect against insulin resistance . In general, dietary studies evaluating n-3PUFA efficacy in different model systems rely on low doses , in which ~5% fish or flaxseed oil was used as intervention (corresponding to approximately 2–6% of the total energy as n-3PUFAs).
A few studies have tested the effects of n-3PUFAs at higher doses on functional endpoints. Very little is known about the effects of high doses of perilla, which may have a unique therapeutic function, but may also exert negative side effects, thus raising potential safety issues for the general public. The purpose of the current study is to examine the serum lipids, hepatic fat deposition, insulin resistance, hepatic gene expression involving fatty acid oxidation and synthesis in HP-induced rats.
Body weight and food consumption
HP-feeding increases hepatic fatty acid oxidation
Relative gene expression levels of hepatic fatty acid oxidation enzymes
0.321 ± 0.144
0.869 ± 0.435*
0.248 ± 0.105
0.46 ± 0.214*
HP-feeding induces changes in hepatic lipid synthesis gene expression
Relative gene expression levels of hepatic fatty acid synthesis
0.455 ± 0.153
0.989 ± 0.375*
0.145 ± 0.087
0.404 ± 0.191*
0.372 ± 0.185
0.774 ± 0.327*
Rats fed with high-dose perilla diet display insulin resistance
Being one of the richest sources of ALA, perilla oil consists of 69.11% ALA. After a 16-week dietary treatment with a diet rich in perilla oil, the level of lipids in the serum lowered significantly and hepatic fatty oxidation improved. In contrast, insulin sensitivity, as measured by a euglycemic-hyperinsulinemic clamp, was decreased by the perilla oil-rich diet.
Excessive ALA intake did not cause significant increases in body weight or total body fat in the HP group , which is similar to the role of EPA/DHA used to prevent obesity and overweightness . Contrarily, after high-fat diet derived from lard or soybean oil were fed to rats or mice, the results showed that the animals had severe intra-abdominal fat and fat deposition, and their body weights were much higher than those of the control group [18–20]. These results suggest that perilla may affect triglyceride deposition in adipose tissue and fat cell activities (such as cell differentiation and cytokine secretion).
In the present study, the serum levels of triglycerides and total cholesterol of rats in the HP group decreased by 86.5 and 40.2%, respectively, compared with those in the control group. In accord with our data, when the mice were respectively fed a high-ALA diet (12% ALA and 4% LA) and a high-LA diet (12% LA and 3% ALA), the serum levels of total cholesterol of the mice fed with the high-dose ALA decreased significantly after 35 days of feeding . Clinical trials demonstrated that patients with metabolic syndrome had a daily ALA intake of 3.5 g/d on their body weight, and their serum levels of triglycerides and total cholesterol decreased significantly after six months of dietary intervention . Therefore, the data suggest taking high doses of ALA was effective in their accepted role of lowering TG and TCH, and this method may be used to treat patients to whom statins are clinically not applicable. However, the n-3 PUFAs currently used mainly originate from marine products (EPA/DHA) [23–25], while few studies have focused on ALA. In addition, the serum levels of high-density lipoprotein cholesterol in the HP group were significantly lower than those in the control group. The reason for this result may be that peripheral cholesterol does not require being transported to the liver, due to cholesterol reduction.
Liver plays a central role in maintaining energy balance and contributing to energy storage in the fed state. The results of the present study show that, compared with the control group, the hepatic mRNA levels of PPAR-α and CPT1A in the HP group increased by 171 and 85%, respectively, with a significant increase in hepatic CPT1A protein expression. However, no difference in hepatic PPAR-α protein expression was shown, suggesting that the high-perilla intake enhanced β-oxidation. 3 T3-L1 cells were treated with ALA, and by DNA microarray analysis the results show that a 1.7-fold increase occurred in the CPT-1a gene expression . In animal experiments, it has been proven that ALA may enhance fatty acid oxidation. When rats were fed with flaxseed oil and perilla oil, the mRNA expression levels of hepatic CPT-I and CPT-II significantly increased, but no effect was shown in terms of fatty acid synthesis . Gonzalez-Manan D. fed rats with chia (Salvia hispanica) and rosa mosqueta (Rosa rubiginosa) rich in ALA, and found significant increases in the PPAR-α transcript level and CPT1A protein expression level after 21 days of feeding . In the present study, the mRNA expressions of hepatic SREBP-1, FASN and ACC of rats in the HP group were significantly higher, while the protein expressions of FASN and ACC were significantly lower, compared with those of the control group. In addition, the SREBP-1 protein expression showed no significant difference between the two groups. These results indicate that the high-dose ALA inhibited fat synthesis by regulating the translation pathway. SREBP-1 has been found to be a positive transcriptional regulator of the cytosolic lipogenic enzymes, which work in sequence to citrate carrier (CIC). Direct evidence was provided that PUFA decrease CIC gene promoter activity, the CIC transcriptional suppression by PUFA was clearly mediated by the SRE/SREBP-1 regulatory system as its effects on CIC promoter-driven luciferase activity was abolished by mutations in the SRE site of the CIC gene [29–31]. However, the rats in the HP group were given a long-term diet with high energy, and excessive fat deposition did not occur in the liver, due to an increase in fatty acid oxidation and a decrease protein expression of key enzymes in fat synthesis. This finding is in agreement with the observation, obese Zucker rats were fed a diet containing 4% ALA, and hepatic fat accumulation was also significantly inhibited after one month of feeding .
In the present study, the mass proportion of ALA in the high-fat diet was 15.74%, and the data from the 16-week clamp experiment show a significant reduction in insulin sensitivity in the HP group. In our previous studies, rats were fed a high-fat diet with the same proportion of perilla, and their insulin sensitivity indexes also decreased significantly after eight weeks of feeding . There have been very few studies in this area to directly compare our data to. However, in terms of application in humans, one study found that an intake of high-dose long-chain n-3 PUFAs (5–8 g/d) increased the blood glucose level in patients with type II diabetes . The reason for this insulin resistance caused by long-term excessive ALA may be that the activity of fatty acid β-oxidation leads to acetyl-CoA accumulation, then pyruvate dehydrogenase activity inhibited by excessive intracellular acetyl-CoA causes citric acid accumulation. As a potential inhibitor of phosphofructokinase, citric acid blocks glucose oxidation in the initial stage, resulting in a decrease in the glucose transportation rate of GLUT4 . Many studies have shown that an excessive saturated fat intake caused an increase of FFA, and elevated FFA had a “toxic” effect on the body, causing damage to the pancreatic beta cell function, promoting cell apoptosis, and resulting in impaired glucose-stimulated insulin secretion . Male Sprague–Dawley rats were fed a chow-diet or a diet high in saturated fat or PUFA (derived from lard and coconut oil or pufa derived from safflower oil). The results show that after 8 weeks, both high-fat diets increased the plasma FFA by 30% . However, excessive ALA intake did not cause elevated serum FFA levels of the rats in the HP group.
After long-term excessive perilla intake, no significant changes were shown in the body weight, hepatic fat deposition or intra-abdominal fat of the rats. In addition, a significant reduction was seen in the serum lipid level, as well as significant increases in the expressions of key enzymes in fatty acid oxidation, along with significant decreases in the protein expressions of key enzymes in fatty acid synthesis. However, the experimental results of the insulin sensitivity reduction will incite interest in researchers studying ALA dosage. More studies regarding the functions and mechanisms of ALA in the bodies of animals and their verification in the human body must be conducted in order to determine the most effective doses of ALA for prevention and treatment.
We have observed that excessive perilla oil intake may significantly lower serum lipids, strengthen hepatic fatty acid oxidation, and inhibit hepatic fatty acid synthesis, but lead to insulin resistance in rat. Further studies are needed to elucidate the precise mechanism of ALA in the bodies of animal and their verification in the human body must be conducted in order to determine the most effective dose of ALA for prevention and treatment.
Materials and methods
Animals and diet
Dietary energy levels and energy percentages
Fat: Protein: Carbohydrate
10.31%: 20.20%: 69.49%
45.73%: 19.67%: 34.59%
Types and levels of dietary fatty acids
Fatty acids in diet, g/100 g
Upon completion of the experiments, all rats were weighed and blood was collected from the anesthetized animals into blood collection tubes after an overnight fast (12 h). After standing for 30 min, the serum was prepared by centrifugation of blood at 1000 × g for 10 min at 4°C and stored at −80°C until analysis. Serum triglyceride (TG), total cholesterol (TCH), high density lipoprotein-cholesterol (HDL-c) and glucose (GLU) were measured by means of enzymatic and colorimetric methods, using assay kits (Sinopharm Chemical Reagent Beijing Co., Ltd, China). Free fatty acid (FFA) and insulin (INS) concentration were determined using rat FFA and insulin ELISA kits (Novateinbio INC), respectively. LDL cholesterol was calculated according to the method of Friedewald et al. .
Real-time quantitative PCR
Primers for analysis of transcription level of gene expression
R 5'- GCAGCAGTGGAAGAATCG-3'
F 5'–CCC ATC TAT GAG GGT TAC GC-3'
R 5'-TTT AAT GTC ACG CAC GAT TTC-3'
Total proteins were prepared from livers (~100 mg), as previously described . The proteins were resolved by SDS-PAGE at 80 V for 30 min, followed by 120 V for 100 min, then transferred to polyvinylidene difluoride membranes at 250 mA for 2 h. Membranes were blocked for 1 h at room temperature, with PBS containing 0.1% tween and 5% skim milk powder, and incubated with mouse monoclonal anti-PPARα antibodies (1:5000, 52 kDa), mouse monoclonal anti-CPT1A antibodies (1:5000, 88 kDa), mouse monoclonal anti-SREBP-1 antibodies (1:5000, 65 kDa), rabbit monoclonal anti-fatty acid synthase antibodies (1:5000, 273 kDa), rabbit monoclonal anti-acetyl coenzyme A carboxylase antibodies (1:5000, 265 kDa), and mouse monoclonal anti-beta actin antibodies (1:5000, 42 kDa) (all antibodies were purchased from Abcam Inc., USA), overnight at 4°C, then washed for 3 × 10 min with PBS containing 0.1% tween. After incubation with the appropriate secondary antibody for 1 h at room temperature, the membranes were washed for 3 × 10 min with PBS. Then the bands were visualized by ECL and quantified densitometry.
Euglycemic-hyperinsulinemic clamp study
After 16 weeks of feeding, the clamp was done. The rats were anesthetized with isoflurane (Sinopharm Chemical Reagent Beijing Co., Ltd, China) after fasting overnight. The left common carotid artery and right jugular vein were catheterized as previously described . The clamps were then performed 4–5 d later after complete recovery of the rats from the operation. Rats (n =4 per group) fasted for 12 h, were infused with human insulin (Humulin R, Novo Nordisk) into the venous circulation, at a rate of 4 mU · kg-1 min-1 for 2 h. Throughout the infusion, the carotid artery was assessed every 10 min using a blood glucose meter(One Touch Uitra, Lifescan). Titration of glucose continues until stable glucose readings are achieved. Stable glucose levels over a time course of a minimum of 30 min. Glucose levels and glucose infusion rates during this stable period are recorded and reported. Results provide an index of whole body insulin sensitivity.
Oil red O staining
For the detection of neutral lipids, portions of liver were rapidly frozen in liquid nitrogen and embedded in Tissue-Tek. 5 μm cryosections were mounted on the microscope slides and air-dried for 2 h. After fixation in 4% neutral formaldehyde for 10 min, sections were stained with oil red O, with 0.5% oil red O dissolved in propylene glycol for 10 min at 60°C. The sliced sections were then counterstained.
The results are presented as means ± standard error. The differences among two diet groups were analyzed by Student’s t-test within the SAS version 9.0 statistical package. Differences were considered to be significant at p < 0.05.
High density lipoprotein cholesterol
Low density lipoprotein cholesterol
Free fatty acid
Peroxisome proliferator activated receptors-α
Carnitine palmitoyltransferase 1A
Fatty acid synthase
Sterol Regulatory element binding protein-1
acetyl coenzyme A carboxylase.
This work was supported by National Natural Science Foundation of China (No. 31071986).
- Manrique C, DeMarco VG, Aroor AR, Mugerfeld I, Garro M, Habibi J, Hayden MR, Sowers JR: Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet. Endocrinology. 2013, 154 (10): 3632-3642. 10.1210/en.2013-1256View ArticlePubMed
- Kerley-Hamilton JS, Trask HW, Ridley CJ, Dufour E, Ringelberg CS, Nurinova N, Wong D, Moodie KL, Shipman SL, Moore JH: Obesity is mediated by differential aryl hydrocarbon receptor signaling in mice fed a Western diet. Environ Health Perspect. 2012, 120 (9): 1252-1259. 10.1289/ehp.1205003PubMed CentralView ArticlePubMed
- Bielohuby M, Sisley S, Sandoval DA, Herbach N, Zengin A, Fischereder M, Menhofer D, Stoehr BJ, Stemmer K, Wanke R: Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets. Am J Physiol Endocrinol Metab. 2013, 305 (9): E1059-1070. 10.1152/ajpendo.00208.2013View ArticlePubMed
- Choi S, Choi Y, Kim S, Jang J, Park T: Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice. Food Chem. 2013, 141 (4): 3627-3635. 10.1016/j.foodchem.2013.06.028View ArticlePubMed
- Susaki E, Nakayama KI: An animal model manifesting neurodegeneration and obesity. Aging (Albany NY). 2010, 2 (7): 453-456.
- Buettner R, Scholmerich J, Bollheimer LC: High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring). 2007, 15 (4): 798-808. 10.1038/oby.2007.608View Article
- Gao Q, Liu Y, Zhang T: Effect of Different Types of Fatty Acids on Serum Biochemical Indicator and Insulin Resistance in SD Rats. Lab Anim Sci. 2010, 01: 16-21.
- Smink W, Gerrits WJ, Gloaguen M, Ruiter A, van Baal J: Linoleic and alpha-linolenic acid as precursor and inhibitor for the synthesis of long-chain polyunsaturated fatty acids in liver and brain of growing pigs. Animal. 2012, 6 (2): 262-270. 10.1017/S1751731111001479View ArticlePubMed
- Lenihan-Geels G, Bishop KS, Ferguson LR: Alternative sources of omega-3 fats: can we find a sustainable substitute for fish?. Nutrients. 2013, 5 (4): 1301-1315. 10.3390/nu5041301PubMed CentralView ArticlePubMed
- Calder PC: n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006, 83 (6 Suppl): 1505S-1519S.PubMed
- Delarue J, LeFoll C, Corporeau C, Lucas D: N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?. Reprod Nutr Dev. 2004, 44 (3): 289-299. 10.1051/rnd:2004033View ArticlePubMed
- Ghafoorunissa I, Rajkumar L, Acharya V: Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J Nutr. 2005, 135 (11): 2634-2638.PubMed
- Ghafoorunissa I, Natarajan S: Substituting dietary linoleic acid with alpha-linolenic acid improves insulin sensitivity in sucrose fed rats. Biochim Biophys Acta. 2005, 1733 (1): 67-75. 10.1016/j.bbalip.2004.12.003View ArticlePubMed
- Rockett BD, Harris M, Shaik SR: High dose of n-3 polyunsaturated fatty acid diet lowers activity of mice. Prostaglandins Leukot Essent Fatty Acids. 2011, 86 (3): 137-140.PubMed CentralView ArticlePubMed
- Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18 (6): 499-502.PubMed
- Poudyal H, Panchal SK, Ward LC, Brown L: Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. J Nutr Biochem. 2012, 24 (6): 1041-1052.View ArticlePubMed
- Golub N, Geba D, Mousa SA, Williams G, Block RC: Greasing the wheels of managing overweight and obesity with omega-3 fatty acids. Med Hypotheses. 2011, 77 (6): 1114-1120. 10.1016/j.mehy.2011.09.016PubMed CentralView ArticlePubMed
- Pence BD, Dipietro LA, Woods JA: Exercise speeds cutaneous wound healing in high-fat diet-induced obese mice. Med Sci Sports Exerc. 2012, 44 (10): 1846-1854. 10.1249/MSS.0b013e31825a5971View ArticlePubMed
- Lim HH, Lee SO, Kim SY, Yang SJ, Lim Y: Anti-inflammatory and antiobesity effects of mulberry leaf and fruit extract on high fat diet-induced obesity. Exp Biol Med (Maywood). 2013, 238 (10): 1160-1169. 10.1177/1535370213498982View Article
- la Fleur SE, Akana SF, Manalo SL, Dallman MF: Interaction between corticosterone and insulin in obesity: regulation of lard intake and fat stores. Endocrinology. 2004, 145 (5): 2174-2185. 10.1210/en.2003-1359View ArticlePubMed
- Javadi M, Geelen MJ, Lemmens AG, Lankhorst A, Schonewille JT, Terpstra AH, Beynen AC: The influence of dietary linoleic and alpha-linolenic acid on body composition and the activities of key enzymes of hepatic lipogenesis and fatty acid oxidation in mice. J Anim Physiol Anim Nutr (Berl). 2007, 91 (1–2): 11-18.View Article
- Baxheinrich A, Stratmann B, Lee-Barkey YH, Tschoepe D, Wahrburg U: Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of alpha-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome. Br J Nutr. 2012, 108 (4): 682-691. 10.1017/S0007114512002875View ArticlePubMed
- Dewell A, Marvasti FF, Harris WS, Tsao P, Gardner CD: Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. J Nutr. 2011, 141 (12): 2166-2171. 10.3945/jn.111.142240PubMed CentralView ArticlePubMed
- Gladine C, Roy NC, Rigaudiere JP, Laillet B, Da Silva G, Joly C, Pujos-Guillot E, Morio B, Feillet-Coudray C, McNabb WC: Increasing intake of long-chain n-3 PUFA enhances lipoperoxidation and modulates hepatic gene expression in a dose-dependent manner. Br J Nutr. 2011, 107 (9): 1-20.
- Last AR, Ference JD, Falleroni J: Pharmacologic treatment of hyperlipidemia. Am Fam Physician. 2011, 84 (5): 551-558.PubMed
- Fukumitsu S, Villareal MO, Onaga S, Aida K, Han J, Isoda H: alpha-Linolenic acid suppresses cholesterol and triacylglycerol biosynthesis pathway by suppressing SREBP-2, SREBP-1a and -1c expression. Cytotechnology. 2012, 65 (6): 899-PubMed CentralView ArticlePubMed
- Ide T: Effect of dietary alpha-linolenic acid on the activity and gene expression of hepatic fatty acid oxidation enzymes. Biofactors. 2000, 13 (1–4): 9-14.View ArticlePubMed
- Gonzalez-Manan D, Tapia G, Gormaz JG, D'Espessailles A, Espinosa A, Masson L, Varela P, Valenzuela A, Valenzuela R: Bioconversion of alpha-linolenic acid to n-3 LCPUFA and expression of PPAR-alpha, acyl Coenzyme A oxidase 1 and carnitine acyl transferase I are incremented after feeding rats with alpha-linolenic acid-rich oils. Food Funct. 2012, 3 (7): 765-772. 10.1039/c2fo30012eView ArticlePubMed
- Pettinelli P, Del Pozo T, Araya J, Rodrigo R, Araya AV, Smok G, Csendes A, Gutierrez L, Rojas J, Korn O: Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Biochim Biophys Acta. 2009, 1792 (11): 1080-1086. 10.1016/j.bbadis.2009.08.015View ArticlePubMed
- Infantino V, Iacobazzi V, De Santis F, Mastrapasqua M, Palmieri F: Transcription of the mitochondrial citrate carrier gene: role of SREBP-1, upregulation by insulin and downregulation by PUFA. Biochem Biophys Res Commun. 2007, 356 (1): 249-254. 10.1016/j.bbrc.2007.02.114View ArticlePubMed
- Price PT, Nelson CM, Clarke SD: Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr Opin Lipidol. 2000, 11 (1): 3-7. 10.1097/00041433-200002000-00002View ArticlePubMed
- Murase T, Aoki M, Tokimitsu I: Supplementation with alpha-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation of beta-oxidation in Zucker fatty rats. Biochim Biophys Acta. 2005, 1733 (2–3): 224-231.View ArticlePubMed
- Tao Z, Yuan L, Shuang Z: The effect of high-fat diet rich in n-3、n-6PUFA on blood lipids and insulin sensitivity in rats. ACTA Nutrimenta SINICA. 2012, 12 (06): 615-618.
- Abeywardena MY, Patten GS: Role of omega3 Longchain polyunsaturated fatty acids in reducing cardio-metabolic risk factors. Endocr Metab Immune Disord Drug Targets. 2011, 11 (3): 232-246. 10.2174/187153011796429817View ArticlePubMed
- Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest. 2000, 106 (2): 171-176. 10.1172/JCI10583PubMed CentralView ArticlePubMed
- Shao S, Yang Y, Yuan G, Zhang M, Yu X: Signaling molecules involved in lipid-induced pancreatic beta-cell dysfunction. DNA Cell Biol. 2013, 32 (2): 41-49. 10.1089/dna.2012.1874PubMed CentralView ArticlePubMed
- Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA, Watt MJ: Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol. 2006, 100 (5): 1467-1474. 10.1152/japplphysiol.01438.2005View ArticlePubMed
- Jolita C, Van den Broek NM, Klaas N, Jeneson JA, Houten SM, Prompers JJ: Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats. Biochim Biophys Acta. 2011, doi:10.1016/j.bbalip.2011.05.005:1–11,
- Hughey CC, Hittel DS, Johnsen VL, Shearer J: Hyperinsulinemic-euglycemic clamp in the conscious rat. J Vis Exp. 2011, 48: doi:10.3791/2432,
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.